e-learning
resources
Vienna 2012
Monday, 03.09.2012
New drug targets and pre-clinical models for respiratory diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A comparison of anti-inflammatory compounds in a steroid-insensitive mouse tobacco smoke model
V. Russell, P. Woodman, A. Connolly, D. Spicer, A. Young (Slough, United Kingdom)
Source:
Annual Congress 2012 - New drug targets and pre-clinical models for respiratory diseases
Session:
New drug targets and pre-clinical models for respiratory diseases
Session type:
Oral Presentation
Number:
2805
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Russell, P. Woodman, A. Connolly, D. Spicer, A. Young (Slough, United Kingdom). A comparison of anti-inflammatory compounds in a steroid-insensitive mouse tobacco smoke model. Eur Respir J 2012; 40: Suppl. 56, 2805
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
The interaction of cigarette smoke and allergens in a mouse model of asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 736s
Year: 2007
Tiotropium bromide exerts anti-inflammatory activity in a cigarette smoke mouse model of COPD
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009
Adjuvant and anti-inflammatory properties of cigarette smoke in murine models of allergic airways inflammation
Source: Annual Congress 2008 - Understanding allergic airway inflammation with the help of animal models
Year: 2008
Cigarette smoke in mice, rats and guinea-pigs: value to the study of pathogenic factors involved in COPD
Source: Annual Congress 2005 - PG11 - Experimental models for COPD and asthma
Year: 2005
The use of toxicogenomics to identify biomarkers of exposure in an airway epithelium model exposed to tobacco smoke components
Source: Eur Respir J 2006; 28: Suppl. 50, 825s
Year: 2006
Potent anti-inflammatory effects of the highly selective iNOS inhibitor Byk402750 in a mouse model of cigarette smoke induced inflammation
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD
Year: 2008
Comparison of the effects of e-cigarette vapor vs cigarette smoke on lung function and inflammation in mice
Source: International Congress 2015 – Emerging data on (e-)cigarettes and their health hazards
Year: 2015
Antioxidant properties of mate tea in mouse lung exposed to cigarette smoke
Source: Annual Congress 2007 - Molecular pathogenesis: focus on COPD and asthma
Year: 2007
Comparison of electronic cigarette vs. cigarette smoke extract on macrophage function
Source: International Congress 2017 – Cigarette smoke and particulate matter: basic science and clinical aspects
Year: 2017
The antiinflammatory and antioxidant effect of tiotropium bromide in subacute cigarette exposure mouse model
Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis
Year: 2015
The effects of electronic cigarette vapour on the lung: direct comparison to tobacco smoke
Source: Eur Respir J, 51 (4) 1701661; 10.1183/13993003.01661-2017
Year: 2018
Therapeutic neutralization of the matrikine PGP suppresses the development of lung emphysema in cigarette smoke exposed mice
Source: International Congress 2016 – Mechanisms of disease
Year: 2016
Comparative analysis of tobacco smoke products and biological effects in hubble-bubble (sheesha) and cigarette smokers
Source: Eur Respir J 2004; 24: Suppl. 48, 304s
Year: 2004
COPD fibroblasts are more responsive to cigarette smoke exposure
Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis
Year: 2009
Characterisation of the dose response of a human airway epithelium model to tobacco smoke components
Source: Eur Respir J 2006; 28: Suppl. 50, 824s
Year: 2006
Alveolar changes in a chronic tobacco smoke inhalation COPD mouse model
Source: Annual Congress 2008 - The biology of smoking and COPD
Year: 2008
Neu-164, a novel antioxidant and anti-inflammatory compound, reduces cigarette smoke-induced lung inflammation
Source: Annual Congress 2008 - COPD
Year: 2008
The effect of active and passive smoking on inhaled drugs in respiratory patients
Source: Eur Respir Mon; 2008: 42: 100–105
Year: 2008
Dynamic global gene expression shows mitigation of the effects of cigarette smoke extract by antioxidants in airway cells
Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases
Year: 2008
NADPH oxidases are regulated in a mouse model of tobacco smoke induced COPD
Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of COPD
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept